Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Tracon Pharmaceuticals Inc. · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
metastatic castrate-resistant prostate cancer, adenocarcinoma, prostate, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 801228
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.